ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer

BACKGROUND: Ovarian cancer is the deadliest type of malignant gynecological tumor. Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are involved ovarian cancer and are closely related to adverse outcomes. However, the immunosuppressive mechanism of PMN-MDSCs remains elusive. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huanhuan, Yang, Keqing, Pang, Lingxiao, Fei, Jing, Zhu, Yongliang, Zhou, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950970/
https://www.ncbi.nlm.nih.gov/pubmed/36822671
http://dx.doi.org/10.1136/jitc-2022-005527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950970/
https://www.ncbi.nlm.nih.gov/pubmed/36822671
http://dx.doi.org/10.1136/jitc-2022-005527

Ejemplares similares